Logo image of CYN

CYNGN INC (CYN) Stock Fundamental Analysis

NASDAQ:CYN - Nasdaq - US23257B2060 - Common Stock - Currency: USD

7.76  +0.69 (+9.76%)

After market: 7.4601 -0.3 (-3.86%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CYN. CYN was compared to 284 industry peers in the Software industry. While CYN has a great health rating, there are worries on its profitability. CYN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CYN has reported negative net income.
In the past year CYN has reported a negative cash flow from operations.
In the past 5 years CYN always reported negative net income.
CYN had a negative operating cash flow in each of the past 5 years.
CYN Yearly Net Income VS EBIT VS OCF VS FCFCYN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of CYN (-266.17%) is worse than 97.46% of its industry peers.
CYN has a Return On Equity of -339.50%. This is amonst the worse of the industry: CYN underperforms 86.23% of its industry peers.
Industry RankSector Rank
ROA -266.17%
ROE -339.5%
ROIC N/A
ROA(3y)-94.96%
ROA(5y)-95.24%
ROE(3y)-109.77%
ROE(5y)-109.18%
ROIC(3y)N/A
ROIC(5y)N/A
CYN Yearly ROA, ROE, ROICCYN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -50 -100 -150 -200

1.3 Margins

CYN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CYN Yearly Profit, Operating, Gross MarginsCYN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -2K -4K -6K

More info and screens

8

2. Health

2.1 Basic Checks

CYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CYN has been reduced compared to 1 year ago.
CYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CYN Yearly Shares OutstandingCYN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M
CYN Yearly Total Debt VS Total AssetsCYN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 25.75 indicates that CYN is not in any danger for bankruptcy at the moment.
CYN's Altman-Z score of 25.75 is amongst the best of the industry. CYN outperforms 94.93% of its industry peers.
There is no outstanding debt for CYN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 25.75
ROIC/WACCN/A
WACC14.07%
CYN Yearly LT Debt VS Equity VS FCFCYN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

2.3 Liquidity

CYN has a Current Ratio of 2.43. This indicates that CYN is financially healthy and has no problem in meeting its short term obligations.
CYN has a Current ratio of 2.43. This is in the better half of the industry: CYN outperforms 66.67% of its industry peers.
CYN has a Quick Ratio of 2.22. This indicates that CYN is financially healthy and has no problem in meeting its short term obligations.
CYN has a better Quick ratio (2.22) than 65.94% of its industry peers.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 2.22
CYN Yearly Current Assets VS Current LiabilitesCYN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

CYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.18%, which is quite impressive.
Looking at the last year, CYN shows a very negative growth in Revenue. The Revenue has decreased by -94.01% in the last year.
EPS 1Y (TTM)56.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.43%
Revenue 1Y (TTM)-94.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%90.4%

3.2 Future

Based on estimates for the next years, CYN will show a very strong growth in Earnings Per Share. The EPS will grow by 24.80% on average per year.
The Revenue is expected to grow by 151.86% on average over the next years. This is a very strong growth
EPS Next Y71.85%
EPS Next 2Y34.67%
EPS Next 3Y24.8%
EPS Next 5YN/A
Revenue Next Year14.59%
Revenue Next 2Y84.97%
Revenue Next 3Y151.86%
Revenue Next 5YN/A

3.3 Evolution

CYN Yearly Revenue VS EstimatesCYN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
CYN Yearly EPS VS EstimatesCYN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 -20 -40 -60 -80 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CYN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CYN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYN Price Earnings VS Forward Price EarningsCYN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYN Per share dataCYN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20 -25

4.3 Compensation for Growth

A more expensive valuation may be justified as CYN's earnings are expected to grow with 24.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.67%
EPS Next 3Y24.8%

More info and screens

0

5. Dividend

5.1 Amount

CYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYNGN INC

NASDAQ:CYN (2/21/2025, 8:11:34 PM)

After market: 7.4601 -0.3 (-3.86%)

7.76

+0.69 (+9.76%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)03-07 2025-03-07/amc
Inst Owners12.74%
Inst Owner Change584.39%
Ins Owners0.46%
Ins Owner Change0%
Market Cap212.62M
Analysts80
Price Target157.72 (1932.47%)
Short Float %2.62%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.52%
Min EPS beat(2)23.9%
Max EPS beat(2)49.13%
EPS beat(4)3
Avg EPS beat(4)10.5%
Min EPS beat(4)-32.01%
Max EPS beat(4)49.13%
EPS beat(8)7
Avg EPS beat(8)9.6%
EPS beat(12)8
Avg EPS beat(12)-44.1%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-95.93%
Min Revenue beat(2)-98.41%
Max Revenue beat(2)-93.44%
Revenue beat(4)0
Avg Revenue beat(4)-84.26%
Min Revenue beat(4)-98.48%
Max Revenue beat(4)-46.72%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.83%
EPS NQ rev (1m)12.3%
EPS NQ rev (3m)12.3%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-60.2%
Revenue NQ rev (3m)-60.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2082.1
P/FCF N/A
P/OCF N/A
P/B 31.98
P/tB 41.2
EV/EBITDA N/A
EPS(TTM)-26.85
EYN/A
EPS(NY)-10.95
Fwd EYN/A
FCF(TTM)-0.78
FCFYN/A
OCF(TTM)-0.75
OCFYN/A
SpS0
BVpS0.24
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -266.17%
ROE -339.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-94.96%
ROA(5y)-95.24%
ROE(3y)-109.77%
ROE(5y)-109.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 93.09%
Cap/Sales 863.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.43
Quick Ratio 2.22
Altman-Z 25.75
F-Score2
WACC14.07%
ROIC/WACCN/A
Cap/Depr(3y)109.6%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.43%
EPS Next Y71.85%
EPS Next 2Y34.67%
EPS Next 3Y24.8%
EPS Next 5YN/A
Revenue 1Y (TTM)-94.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%90.4%
Revenue Next Year14.59%
Revenue Next 2Y84.97%
Revenue Next 3Y151.86%
Revenue Next 5YN/A
EBIT growth 1Y4.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.99%
EBIT Next 3Y26.89%
EBIT Next 5YN/A
FCF growth 1Y-40.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.4%
OCF growth 3YN/A
OCF growth 5YN/A